Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by edroseon Nov 19, 2021 11:28am
133 Views
Post# 34145818

there's no assets left in this company since

there's no assets left in this company sincethey sold most assets and they put a hold on developping 4050 great potential ,there excuse to stop research  :    we are analysing pk data   on the few patients they had in their study     
 
scientist will testify that it doesn't take long to analyse this data     why did they stop alstom study etc     they probably don't want to spend money on r&d    and they will pay back loan to themselves  since salp which is based in cayman island to avoid paying candian taxes is owned by thomvest 
<< Previous
Bullboard Posts
Next >>